Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Sweeney
Dana-Farber Cancer Institute and Harvard Medical School
Study Chair - Tamim Niazi
Jewish General Hospital and McGill University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
93 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Border Medical Oncology Research Unit
Albury, New South Wales, Australia
- Gosford Hospital
Gosford, New South Wales, Australia
- Calvary Mater Newcastle
Newcastle, New South Wales, Australia
- Genesiscare Newcastle
Newcastle, New South Wales, Australia
- Shoalhaven District Memorial Hospital
Nowra, New South Wales, Australia
- Campbelltown Hospital
Sydney, New South Wales, Australia
- Chris O'Brien Lifehouse
Sydney, New South Wales, Australia
- Liverpool Hospital
Sydney, New South Wales, Australia
- Northern Cancer Institute
Sydney, New South Wales, Australia
- Prince of Wales Hospital
Sydney, New South Wales, Australia
- St George Hospital
Sydney, New South Wales, Australia
- St Vincent'S Public Hospital
Sydney, New South Wales, Australia
- Sydney Adventist Hospital
Sydney, New South Wales, Australia
- Wollongong Hospital
Wollongong, New South Wales, Australia
- Ropart
Brisbane, Queensland, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Icon Cancer Centre
Southport, Queensland, Australia
- Townsville Hospital
Townsville, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Ashford Cancer Centre Research
Kurralta Park, South Australia, Australia
- Icon Cancer Centre Hobart
Hobart, Tasmania, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- Peter Maccallum Cancer Centre - Bendigo Campus
Bendigo, Victoria, Australia
- Peter Maccallum Cancer Centre (moorabbin Campus)
Bentleigh East, Victoria, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- Genesiscare Cabrini (gandel Wing), Cabrini Hospital Malvern
Malvern, Victoria, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- the Alfred Hospital
Melbourne, Victoria, Australia
- Sunshine Hospital
St Albans, Victoria, Australia
- Latrobe Regional Hospital
Traralgon, Victoria, Australia
- Fiona Stanley Hospital
Murdoch, Western Australia, Australia
- Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bc Cancer Agency (bcca) Fraser Valley
Surrey, British Columbia, Canada
- Western Manitoba Cancer Centre - Prairie Mountain Health
Brandon, Manitoba, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Regional Health Authority B, Zone 2 Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Dr. H. Bliss Murphy Cancer Centre, St. John'S
St. John's, Newfoundland and Labrador, Canada
- Kingston Health Sciences Centre
Kingston, Ontario, Canada
- Queen Elizabeth Ii Health Sciences Centre
London, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2020
- Primary completion
- 31 Jan 2028
- Completion
- 31 Jul 2028
- Last update posted
- 6 May 2026
- Registered enrollment
- 1,100
- Registry id
- NCT04136353
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.